Literature DB >> 3003482

Diurnal rhythm of alpha 2-noradrenergic receptors in the paraventricular nucleus and other brain areas: relation to circulating corticosterone and feeding behavior.

M Jhanwar-Uniyal, C R Roland, S F Leibowitz.   

Abstract

The paraventricular nucleus alpha 2-noradrenergic system and the glucocorticoid hormone, corticosterone, are known to modulate feeding behavior and exhibit a circadian pattern which may be related to the natural periodicity of feeding in the rat. The results of the present study indicate that the binding of [3H]p-aminoclonidine to alpha 2-noradrenergic receptors specifically in the paraventricular nucleus varies concomitantly with plasma corticosterone levels, as well as spontaneous feeding. A monophasic peak of paraventricular noradrenergic receptor binding is detected at the onset of the dark period, when corticosterone levels are highest and feeding is initiated. On the other hand, the supraoptic nucleus exhibits the reverse diurnal pattern, i.e., a significant decline of [3H]p-aminoclonidine binding at the onset of the dark period. Other hypothalamic and extra-hypothalamic areas fail to show significant changes in alpha 2-noradrenergic receptors as a function of the diurnal cycle. This study supports other evidence indicating a close interaction between circulating corticosterone and alpha 2-noradrenergic receptors in specific hypothalamic areas. It also reveals a potential importance for this interaction in control of the natural feeding rhythm.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003482     DOI: 10.1016/0024-3205(86)90073-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.

Authors:  B G Taksande; N R Kotagale; K T Nakhate; P D Mali; D M Kokare; K Hirani; N K Subhedar; C T Chopde; R R Ugale
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

3.  Norepinephrine and serotonin receptors in the paraventricular nucleus interactively modulate ethanol consumption.

Authors:  C W Hodge; C J Slawecki; A S Aiken
Journal:  Alcohol Clin Exp Res       Date:  1996-12       Impact factor: 3.455

4.  Functional interactions between estrogen and insulin-like growth factor-I in the regulation of alpha 1B-adrenoceptors and female reproductive function.

Authors:  Arnulfo Quesada; Anne M Etgen
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

5.  Nicotine's attenuation of body weight involves the perifornical hypothalamus.

Authors:  Phillip R Kramer; Guoqiang Guan; Paul J Wellman; Larry L Bellinger
Journal:  Life Sci       Date:  2007-06-28       Impact factor: 5.037

6.  The effect of partial noradrenergic denervation on corticosterone secretion in the rat.

Authors:  W M Daniels; A Jaffer; A Searson; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

Review 7.  Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders.

Authors:  D Healy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 8.  G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.

Authors:  Georgina G J Hazell; Charles C Hindmarch; George R Pope; James A Roper; Stafford L Lightman; David Murphy; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  Front Neuroendocrinol       Date:  2011-07-23       Impact factor: 8.606

Review 9.  Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control.

Authors:  Yue Deng; Guorui Deng; Justin L Grobe; Huxing Cui
Journal:  Front Physiol       Date:  2021-06-28       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.